IVD Medical Holding Limited (HK:1931)
:1931
Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.84 - HK$12.86
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$1.39B
Enterprise ValueHK$2.49B
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.84B
Price to Earnings (P/E)109.2
Beta0.60
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Industry StabilityOperating in medical distribution provides structurally stable demand from healthcare providers. That sector tends to generate repeat orders for consumables and devices, supporting predictable revenue streams and reducing cyclicality risk over a multi‑month horizon.
Historically Healthy Operating PerformanceA multi‑year record of healthy operating margins and growth (2021–2024) indicates the company has demonstrated operational competence and pricing or distribution advantages. This historical strength suggests capacity to restore margins if structural headwinds ease.
Sizable Equity BaseDespite recent deterioration, the balance sheet retains a sizable equity base. That equity buffer can absorb shocks, support creditor confidence, and provide capacity to finance working capital or restructure, preserving medium‑term solvency options.
Bears Say
Profitability Collapse In 2025A sharp revenue decline and margin compression in 2025 materially reduces the firm's ability to generate operating earnings. Sustained low margins weaken reinvestment capacity, undermine returns on capital, and can erode competitive position if cost structure cannot be adjusted.
Severe Cash‑Flow DeteriorationLarge negative operating and free cash flows indicate elevated working‑capital strain or cash outlays. Persistent cash deficits force external financing or asset sales, increase liquidity risk, and constrain investment or distributor relationships over the medium term.
Rising LeverageA marked increase in debt‑to‑equity reduces financial flexibility and raises interest and covenant risk. Higher leverage limits strategic options, increases refinancing exposure, and amplifies downside in a prolonged recovery, pressuring long‑term stability.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.84 and its highest was HK$12.86 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$1.39B.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Aug 14, 2026 which is in 85 days.
How were IVD Medical Holding Limited’s earnings last quarter?
IVD Medical Holding Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.003.
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
IVD Medical Holding Limited reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.893%.
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
1.09%
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance services, such as maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents under the IVD brand. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
Technical Analysis
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
ClouDr Group Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―
Options Prices
Currently, No data available
---